Where ScienceTakes Shape

We are a leading early-stage venture capital firm dedicated to investing in the most innovative life science companies in Europe.

By investing early and partnering with visionary CEOs, we strive to have a transformative impact on healthcare.

We leverage our deep sector expertise, entrepreneurial experience, and strong network across academia, industry and clinical research institutions to help build exceptional companies.

This is Thuja

Today’s scientific breakthroughs, tomorrow’s impact.

Latest stories

Meet Dieuwertje Toet, Finance Manager at Thuja

Thuja’s 2024 Impact & ESG Annual Report

Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer

Empowering breakthrough innovations that transform healthcare